| Share Name |
Share Symbol |
Market |
Type |
Share ISIN |
Share Description |
| British & American Investment Trust Plc |
LSE:BAF |
London |
Ordinary Share |
GB0000653112 |
ORD SHS #1 |
| |
Price Change |
% Change |
Share Price |
Shares Traded |
Last Trade |
| |
-1.00 |
-5.0% |
19.00 |
3,567 |
11:38:38 |
| Bid Price |
Offer Price |
High Price |
Low Price |
Open Price |
|
17.00
|
21.00
|
20.00 |
19.00 |
20.00 |
| Industry Sector |
Turnover (m) |
Profit (m) |
EPS - Basic |
PE Ratio |
Market Cap (m) |
|
Equity Investment Instruments
|
1.24
|
0.86
|
2.26
|
8.4
|
5
|
| Last Trade Time |
Trade Type |
Trade Size |
Trade Price |
Currency |
| 16:20:37 |
O |
1,367 |
20.96 |
GBX |
British & American Inves... News
| Trade Time |
Trade Price |
Trade Size |
Trade Value |
Trade Type |
No Trades
| Date | Subject |
|---|
11/7/2020
09:20 | British & American Inves... Daily Update: British & American Investment Trust Plc is listed in the Equity Investment Instruments sector of the London Stock Exchange with ticker BAF. The last closing price for British & American Inves... was 20p.
British & American Investment Trust Plc has a 4 week average price of 17p and a 12 week average price of 17p.
The 1 year high share price is 46.50p while the 1 year low share price is currently 17p.
There are currently 25,000,000 shares in issue and the average daily traded volume is 10,392 shares. The market capitalisation of British & American Investment Trust Plc is £4,750,000.
|
13/3/2014
15:25 | topvest: Looks like the share price has fallen reflecting Geron Corps halving of their share price. I wonder whether they were stupid enough to put more money into Geron at $4 before it crashed to below $2?
|
15/5/2013
08:14 | topvest: Well I've sold out of here as I think, on further analysis, that the share price is overvalued by 10-20% and I think it can only be desperate income seekers keeping the price up. My main issues with this company are:
- Paying unsustainable dividends out of capital with minimal disclosure of the fact that they buy circa. £1.5m of shares before a dividend and sell for a capital loss once the dividend is paid. A crazy policy, but has maintained 16 years of dividend increases at the expense of depleting capital.
- A bit of an obsession with Geron and BioTime which is highly speculative and not really consistent with what the company does otherwise. Can't see any return on this investment for years, unless Geron and BioTime get caught up in a speculative bubble. Geron is at a pretty much all time low and so US holders aren't too excited by the deal on the table!
- Staff costs are £403k which is pushing the Ongoing Charges up to 2.5% - what exactly are the employees doing as film revenues are very small?
- Hugely diminished investment trust portfolio - basically the portfolio will struggle to be sustainable soon as it is being depleted by the crazy dividend policy.
Overall, I think you are unlikely to get 80p back so I have sold out and think myself very fortunate to have made a capital profit of nearly 10% and collected almost 10% yield each year over 3 years. Not bad for a poor investment!
|
09/9/2012
10:21 | topvest: Geron Corp. share price up quite a bit over the last few months. Lets hope they sell this stake in 12m or so if the share price really takes off. They do need to get out of this stake when the time is right in my opinion. Not yet, but if it doubles or triples from where it is now.
|
British & American Inves... share price data is direct from the London Stock Exchange
PLUS1
British & American Investment's NAV Per Share Falls And Payout Slashed